US2019365690A1PendingUtilityA1
Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
Assignee: LIPOPHARMA THERAPEUTICS S LPriority: Mar 16, 2009Filed: Dec 18, 2018Published: Dec 5, 2019
Est. expiryMar 16, 2029(~2.6 yrs left)· nominal 20-yr term from priority
Inventors:Pablo Vicente Escriba RuizXavier Busquets XaubetMaria Laura MartinRafael Alvarez MartinezVictoria Llado Canellas
A61P 25/28A61K 31/201A61K 31/202A61K 31/20A61K 31/661C07C 59/42A61K 31/23A61K 9/0053
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method to treat a cancer in a subject in need thereof comprising administering to the subject an effective amount of a composition comprising at least a polyunsaturated fatty acid selected from the group consisting of
(i) COOH—CHOH—(CH 2 ) 6 —(CH═CH—CH 2 ) 2 —(CH 2 ) 3 —CH 3 (182A1), an acceptable salt, or a combination thereof; (ii) COOH—CHOH—(CH 2 ) 6 —(CH═CH—CH 2 ) 3 —CH 3 (183A1), an acceptable salt, or a combination thereof; (iii) COOH—CHOH—(CH 2 ) 3 —(CH═CH—CH 2 ) 3 —(CH 2 ) 3 —CH 3 (183A2), an acceptable salt, or a combination thereof; (iv) COOH—CHOH—(CH 2 ) 2 —(CH═CH—CH 2 ) 4 —(CH 2 ) 3 —CH 3 (204A1), an acceptable salt, or a combination thereof; (v) COOH—CHOH—(CH 2 ) 2 —(CH═CH—CH 2 ) 5 —CH 3 (205A1), an acceptable salt, or a combination thereof; (vi) COOH—CHOH—CH 2 —(CH═CH—CH 2 ) 6 —CH 3 (226A1), an acceptable salt, or a combination thereof; or, (vii) a combination thereof.
18 . A method to treat a neurodegenerative disease in a subject in need thereof comprising administering to the subject an effective amount of a composition comprising at least a polyunsaturated fatty acid selected from the group consisting of
(i) COOH—CHOH—(CH 2 ) 6 —(CH═CH—CH 2 ) 2 —(CH 2 ) 3 —CH 3 (182A1), an acceptable salt, or a combination thereof; (ii) COOH—CHOH—(CH 2 ) 6 —(CH═CH—CH 2 ) 3 —CH 3 (183A1), an acceptable salt, or a combination thereof; (iii) COOH—CHOH—(CH 2 ) 3 —(CH═CH—CH 2 ) 3 —(CH 2 ) 3 —CH 3 (183A2), an acceptable salt, or a combination thereof; (iv) COOH—CHOH—(CH 2 ) 2 —(CH═CH—CH 2 ) 4 —(CH 2 ) 3 —CH 3 (204A1), an acceptable salt, or a combination thereof; (v) COOH—CHOH—(CH 2 ) 2 —(CH═CH—CH 2 ) 5 —CH 3 (205A1), an acceptable salt, or a combination thereof; (vi) COOH—CHOH—CH 2 —(CH═CH—CH 2 ) 6 —CH 3 (226A1), an acceptable salt, or a combination thereof; or, (vii) a combination thereof.Join the waitlist — get patent alerts
Track US2019365690A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.